Table 1

Safety and procedural aspects of Bronchoscopic Transparenchymal Nodule Access (BTPNA) procedure

SiteSize (mm)Visible at fluoroscopyProcedure
planning time (min)
Nodule access time (min)Fluoroscopy time (min)Intra-procedural adverse eventsTunnel length (mm)PathologyInspection of resection specimenTNMCorrelation with
resection specimens
adverse events
1LUL40Yes104011.6None10Large cell carcinoma*T2aN0M0YesRaised troponin level
2Lingula20Yes15Data not recorded7.09None50Small cell cancer*T1aN0M0YesNone reported
3LLL25No30305.18None60Large cell carcinoma*T1bN0M0 None reported
4LUL31Yes18No sample taken5Sheath could not be directed along optimal pathN/A*T2aN0M0 None reported
5RML22No15266.7None50NSCLC*T1bN0M0 None reported
6LLL22No12133None30NSCLC*T1bN0M0 None reported
7RLL30No25301.8None30NSCLC*T2aN0M0 None reported
8RLL18Yes15173.6None60Adenocarcinoma*T1aN0M0 None reported
9RLL20No30124.2None90NSCLC*T1aN0M0 None reported
10RML28Yes15139.8None70Adenocarcinoma*T1bN0M0 None reported
11LUL17No14No sample takenN/ASheath could not be directed along optimal pathN/A*T1a N0M0N/ANone reported
12LUL31No10152.1None20NSCLC*T2aN0M0YesNone reported
  • Where size is the long axis diameter.

  • *All areas involved in TPNA resected and no concerns identified.

  • LLL, left lower lobe; LUL, left upper lobe; NSCLC, non-small cell lung cancer; RLL, right lower lobe; RML, right middle lobe.